NewLink Genetics to Participate in the Cantor Global Healthcare Conference
September 18 2018 - 9:00AM
NewLink Genetics Corporation (NASDAQ:NLNK) announced today that the
Company will present at the 2018 Cantor Global Healthcare
Conference on Wednesday, October 3, 2018, at 4:00PM ET in New York,
New York.
A live webcast of the presentation will be available on the
Company’s website at www.newlinkgenetics.com in the “Investors
& Media” section under “Events and Presentations.” An archived
edition of the presentation will be available on NewLink Genetics’
website later that day.
About NewLink Genetics Corporation
NewLink Genetics is a clinical-stage
biopharmaceutical company focused on discovering, developing and
commercializing novel immuno-oncology product candidates to improve
the lives of patients with cancer. NewLink Genetics' leading drug
candidate, indoximod, is an investigational, orally available small
molecule designed to harness multiple components of the immune
system to combat cancer. For more information, please
visit www.newlinkgenetics.com and follow us on Twitter
@NLNKGenetics.
Investor Contact:
Lisa MillerDirector of Investor RelationsNewLink
Genetics515-598-2555lmiller@linkp.com
Media Contact:
Sharon CorreiaVP, Integrated
CommunicationsLaVoieHealthScience617-374-8800, ext.
105scorreia@lavoiehealthscience.com
NewLink Genetics (NASDAQ:NLNK)
Historical Stock Chart
From Mar 2024 to Apr 2024
NewLink Genetics (NASDAQ:NLNK)
Historical Stock Chart
From Apr 2023 to Apr 2024